Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. STKE, 21 January 2003
Vol. 2003, Issue 166, p. re1
[DOI: 10.1126/stke.2003.166.re1]

REVIEWS

FXYD Proteins: New Tissue-Specific Regulators of the Ubiquitous Na,K-ATPase

Gilles Crambert and Käthi Geering*

Institute of Pharmacology and Toxicology, University of Lausanne, rue du Bugnon 27, CH-Lausanne, Switzerland.

Abstract: Maintenance of the Na+ and K+ gradients between the intracellular and extracellular milieus of animal cells is a prerequisite for basic cellular homeostasis and for functions of specialized tissues. The Na,K-ATPase, an oligomeric P-type adenosine triphosphatase (ATPase), is composed of a catalytic α subunit and a regulatory β subunit and is the main player that fulfils these tasks. A variety of regulatory mechanisms are necessary to guarantee appropriate Na,K-ATPase expression and activity adapted to changing physiological demands. Recently, a regulatory mechanism was defined that is mediated by interaction of Na,K-ATPase with small proteins of the FXYD family, which possess a single transmembrane domain and so far have been considered as channels or regulators of ion channels. The mammalian FXYD proteins FXYD1 through FXYD7 exhibit tissue-specific distribution. Phospholemman (FXYD1) in heart and skeletal muscle, the {gamma} subunit of Na,K-ATPase (FXYD2) and corticosteroid hormone-induced factor (FXYD4, also known as CHIF) in the kidney, and FXYD7 in the brain associate preferentially with the widely expressed Na,K-ATPase α1-β1 isozyme and modulate its transport activity in a way that conforms to tissue-specific requirements. Thus, tissue- and isozyme-specific interaction of Na,K-ATPase with FXYD proteins contributes to proper handling of Na+ and K+ by the Na,K-ATPase, and ensures correct function in such processes as renal Na+-reabsorption, muscle contraction, and neuronal excitability.

*Corresponding author. Telephone, 41 21 692 5410; fax, 41 21 692 5355; e-mail: kaethi.geering{at}ipharm.unil.ch

Citation: G. Crambert, K. Geering, FXYD Proteins: New Tissue-Specific Regulators of the Ubiquitous Na,K-ATPase. Sci. STKE 2003, re1 (2003).

Read the Full Text

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
V. Deng, V. Matagne, F. Banine, M. Frerking, P. Ohliger, S. Budden, J. Pevsner, G. A. Dissen, L. S. Sherman, and S. R. Ojeda (2007)
Hum. Mol. Genet. 16, 640-650
   Abstract »    Full Text »    PDF »
A third Na+-binding site in the sodium pump.
C. Li, O. Capendeguy, K. Geering, and J.-D. Horisberger (2005)
PNAS 102, 12706-12711
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882